The vacuum being left by US investors is being filled by investors like Sofinnova Partners across the pond. Lets hope they continue to invest those dollars into US companies and not in EU companies. This article is based on an interview with Antoine Papiernik, Managing Partner, Sofinnova Partners where Antoine talks about the change in dynamics to MedTech VC deal flow from his perspective.
Where are all the MedTech VCs? Try looking across the pond.
